{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:12:47Z","timestamp":1792746767499,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["099909"],"award-info":[{"award-number":["099909"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["092283"],"award-info":[{"award-number":["092283"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002542","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:35:06Z","timestamp":1522244106000},"page":"e1002542","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":182,"title":["Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database"],"prefix":"10.1371","volume":"15","author":[{"given":"Balachandran","family":"Kumarendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Manolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna M.","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.","family":"Sitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika N.","family":"Wijeyaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-1279","authenticated-orcid":true,"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"G Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"RA Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"BC Fauser","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"MW O'Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"D Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome","volume":"102","author":"MW O'Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"JK Dowman","year":"2010","journal-title":"QJM"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"MJ Armstrong","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"RJ Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"ref12","article-title":"Mechanisms of Insulin Resistance in Primary and Secondary Non-Alcoholic Fatty Liver","author":"T Jelenik","year":"2017","journal-title":"Diabetes"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"e23235","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis","volume":"14","author":"M Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"E Vassilatou","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0004-28032015000200008","article-title":"Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome","volume":"52","author":"MD Romanowski","year":"2015","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"E Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"ref17","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","author":"J Cai","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"JJ Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"ALL Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2532.1994.1130177.x","article-title":"What are the Read Codes?","volume":"11","author":"N Booth","year":"1994","journal-title":"Health Libr Rev"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/pds.3981","article-title":"Backdating of events in electronic primary health care data: should one censor at the date of last data collection","volume":"25","author":"CJ Sammon","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ref22","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"BT Blak","year":"2011","journal-title":"Inform Prim Care"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"e012461","DOI":"10.1136\/bmjopen-2016-012461","article-title":"Diagnosis and management of polycystic ovary syndrome in the UK (2004\u20132014): a retrospective cohort study","volume":"6","author":"T Ding","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies","volume":"101","author":"AK Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"SS Lim","year":"2013","journal-title":"Obes Rev"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"L Li","year":"2016","journal-title":"Obes Rev"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwv445","article-title":"Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies","volume":"184","author":"ME Karim","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/pds.1770","article-title":"Creating medical and drug code lists to identify cases in primary care databases","volume":"18","author":"S Dave","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Y Vinogradova","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0047279400020341","article-title":"Deprivation","volume":"16","author":"P Townsend","year":"1987","journal-title":"Journal of Social Policy"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"e108498","DOI":"10.1371\/journal.pone.0108498","article-title":"Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care","volume":"9","author":"MG Keane","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"D Glintborg","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6973","key":"ref33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","article-title":"Multiple significance tests: the Bonferroni method","volume":"310","author":"JM Bland","year":"1995","journal-title":"BMJ"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jech.2003.008466","article-title":"Bias","volume":"58","author":"M Delgado-Rodriguez","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CLEP.S118336","article-title":"Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies","volume":"9","author":"I Petersen","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"JM Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"MJ Chen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"H Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife","volume":"112","author":"M Sarkar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref41","article-title":"AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","author":"MW O'Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity","volume":"62","author":"K Anjani","year":"2015","journal-title":"J Hepatol"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/en.2015-1149","article-title":"5alpha-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes","volume":"156","author":"M Nasiri","year":"2015","journal-title":"Endocrinology"},{"key":"ref44","article-title":"MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease","author":"L Schiffer","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis","volume":"16","author":"V Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2009.08.009","article-title":"Interactions of sex hormone-binding globulin with target cells","volume":"316","author":"W Rosner","year":"2010","journal-title":"Molecular and cellular endocrinology"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"RK Semple","year":"2011","journal-title":"Endocr Rev"},{"issue":"13","key":"ref48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"S Franks","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"HS Randeva","year":"2012","journal-title":"Endocr Rev"},{"issue":"6","key":"ref50","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"A Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"H Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"ref52","first-page":"810","article-title":"Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?","volume":"102","author":"S Li","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","article-title":"Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity","volume":"83","author":"S Cassar","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00125-016-3910-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?","volume":"59","author":"CD Byrne","year":"2016","journal-title":"Diabetologia"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T07:04:31Z","timestamp":1604041471000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002542"}},"subtitle":[],"editor":[{"given":"Jenny E","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002542","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]}}}